These are variants in ADA, ALG6, and HPS5. The ALG6 variant Y131H (rs35383149) has been annotated to cause congenital disorder of glycosylation, type Ic, a childhood onset metabolic disorder accompanied by severe neurological symptoms (Miller et al. 2011). Here, HPS5 is linked to metabolic disease.